SE0202516D0 - Novel compounds, their use, and preparation - Google Patents

Novel compounds, their use, and preparation

Info

Publication number
SE0202516D0
SE0202516D0 SE0202516A SE0202516A SE0202516D0 SE 0202516 D0 SE0202516 D0 SE 0202516D0 SE 0202516 A SE0202516 A SE 0202516A SE 0202516 A SE0202516 A SE 0202516A SE 0202516 D0 SE0202516 D0 SE 0202516D0
Authority
SE
Sweden
Prior art keywords
preparation
novel compounds
novel
compounds
Prior art date
Application number
SE0202516A
Other languages
English (en)
Inventor
Bjoern Nilsson
Erik Ringberg
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Priority to SE0202516A priority Critical patent/SE0202516D0/sv
Publication of SE0202516D0 publication Critical patent/SE0202516D0/sv
Priority to EP05023471A priority patent/EP1645558B1/en
Priority to PT05023471T priority patent/PT1645558E/pt
Priority to NZ536664A priority patent/NZ536664A/en
Priority to US10/464,422 priority patent/US7226925B2/en
Priority to DE60321606T priority patent/DE60321606D1/de
Priority to CA002485537A priority patent/CA2485537A1/en
Priority to CNB038141612A priority patent/CN100334082C/zh
Priority to CA2723494A priority patent/CA2723494C/en
Priority to US10/464,181 priority patent/US7129354B2/en
Priority to PCT/SE2003/001044 priority patent/WO2004000830A1/en
Priority to JP2004530934A priority patent/JP4592417B2/ja
Priority to CA2485532A priority patent/CA2485532C/en
Priority to AT05023471T priority patent/ATE398119T1/de
Priority to AU2003237746A priority patent/AU2003237746B8/en
Priority to IL16522003A priority patent/IL165220A0/xx
Priority to DK05023471T priority patent/DK1645558T3/da
Priority to AT03736405T priority patent/ATE334980T1/de
Priority to JP2004530935A priority patent/JP4460450B2/ja
Priority to SI200331283T priority patent/SI1645558T1/sl
Priority to NZ536663A priority patent/NZ536663A/en
Priority to DK03736405T priority patent/DK1529043T3/da
Priority to EP03736405A priority patent/EP1529043B1/en
Priority to ES03736405T priority patent/ES2270051T3/es
Priority to PCT/SE2003/001043 priority patent/WO2004000829A1/en
Priority to AT03760997T priority patent/ATE454383T1/de
Priority to DE60330864T priority patent/DE60330864D1/de
Priority to PT03736405T priority patent/PT1529043E/pt
Priority to AU2003243089A priority patent/AU2003243089B2/en
Priority to ES05023471T priority patent/ES2307102T3/es
Priority to DE60307286T priority patent/DE60307286T2/de
Priority to BR0311970-0A priority patent/BR0311970A/pt
Priority to MXPA04012711A priority patent/MXPA04012711A/es
Priority to EA200500045A priority patent/EA008148B1/ru
Priority to EP03760997A priority patent/EP1513831B1/en
Priority to SI200330493T priority patent/SI1529043T1/sl
Priority to CNB038141310A priority patent/CN100484933C/zh
Priority to NO20050270A priority patent/NO20050270L/no
Priority to NO20050279A priority patent/NO20050279D0/no
Priority to HK05111675.4A priority patent/HK1079526A1/xx
Priority to HK06100135.0A priority patent/HK1080079B/zh
Priority to US11/359,152 priority patent/US7820677B2/en
Priority to CY20061101556T priority patent/CY1106225T1/el
Priority to JP2010002229A priority patent/JP5378241B2/ja
Priority to US12/817,833 priority patent/US8030316B2/en
Priority to US13/234,510 priority patent/US20120004241A1/en
Priority to US13/234,555 priority patent/US8410113B2/en
Priority to JP2013019444A priority patent/JP2013116906A/ja
Priority to US13/768,641 priority patent/US8835439B2/en
Priority to JP2013142942A priority patent/JP2013227336A/ja
Priority to US14/274,131 priority patent/US20140329826A1/en

Links

SE0202516A 2002-06-19 2002-08-26 Novel compounds, their use, and preparation SE0202516D0 (sv)

Priority Applications (51)

Application Number Priority Date Filing Date Title
SE0202516A SE0202516D0 (sv) 2002-08-26 2002-08-26 Novel compounds, their use, and preparation
EP05023471A EP1645558B1 (en) 2002-06-19 2003-06-18 Piperazinylpyrazines as serotonin 5-HT2C receptor modulators
PT05023471T PT1645558E (pt) 2002-06-19 2003-06-18 Piperazinilpirazinas como moduladores do receptor 5-ht2c da serotonina
NZ536664A NZ536664A (en) 2002-06-19 2003-06-18 Piperazinylpyrazine derivative compounds, their use and preparation
US10/464,422 US7226925B2 (en) 2002-06-19 2003-06-18 Compounds, their use and preparation
DE60321606T DE60321606D1 (de) 2002-06-19 2003-06-18 Piperazinylpyrazine als Modulatoren des Serotonin 5-HT2C Rezeptors
CA002485537A CA2485537A1 (en) 2002-06-19 2003-06-18 Novel compounds, their use and preparation
CNB038141612A CN100334082C (zh) 2002-06-19 2003-06-18 制备2－甲基哌嗪衍生物的方法
CA2723494A CA2723494C (en) 2002-06-19 2003-06-18 2-methyl piperazine derivatives for treatment of serotonin-related disorders
US10/464,181 US7129354B2 (en) 2002-06-19 2003-06-18 Process for the preparation of stable acid addition salt of 2,3-disubstituted pyrazine compounds
PCT/SE2003/001044 WO2004000830A1 (en) 2002-06-19 2003-06-18 Novel compounds, their use and preparation
JP2004530934A JP4592417B2 (ja) 2002-06-19 2003-06-18 新規方法
CA2485532A CA2485532C (en) 2002-06-19 2003-06-18 Process for the preparation of 2-methyl piperazine derivatives
AT05023471T ATE398119T1 (de) 2002-06-19 2003-06-18 Piperazinylpyrazine als modulatoren des serotonin 5-ht2c rezeptors
AU2003237746A AU2003237746B8 (en) 2002-06-19 2003-06-18 Novel process
IL16522003A IL165220A0 (en) 2002-06-19 2003-06-18 Novel compounds, their use and preparation
DK05023471T DK1645558T3 (da) 2002-06-19 2003-06-18 Piperazinylpyraziner som serotonin 5-HT2C receptormodulatorer
AT03736405T ATE334980T1 (de) 2002-06-19 2003-06-18 Verfahren zur herstellung von 2-methyl piperazine derivaten.
JP2004530935A JP4460450B2 (ja) 2002-06-19 2003-06-18 新規化合物、その使用および製造法
SI200331283T SI1645558T1 (sl) 2002-06-19 2003-06-18 Piperazinilpirazini kot modulatorji serotonin 5-HT2C receptorja
NZ536663A NZ536663A (en) 2002-06-19 2003-06-18 Process for the preparation of pharmaceutically acceptable salts of selective piperazinyl 5-HT2c receptor ligands
DK03736405T DK1529043T3 (da) 2002-06-19 2003-06-18 Fremgangsmåde til fremstilling af 2-methylpiperazin-derivater
EP03736405A EP1529043B1 (en) 2002-06-19 2003-06-18 Process for the preparation of 2-methyl piperazine derivatives.
ES03736405T ES2270051T3 (es) 2002-06-19 2003-06-18 Procedimiento para la preparacion de derivados de 2-metilpiperazina.
PCT/SE2003/001043 WO2004000829A1 (en) 2002-06-19 2003-06-18 Novel process
AT03760997T ATE454383T1 (de) 2002-06-19 2003-06-18 Neue verbindungen, deren verwendung und herstellung
DE60330864T DE60330864D1 (de) 2002-06-19 2003-06-18 Neue verbindungen, deren verwendung und herstellung
PT03736405T PT1529043E (pt) 2002-06-19 2003-06-18 Processo para a preparação de derivados de 2-metil-piperazina
AU2003243089A AU2003243089B2 (en) 2002-06-19 2003-06-18 Novel compounds, their use and preparation
ES05023471T ES2307102T3 (es) 2002-06-19 2003-06-18 Piperazinilpirazinas como moduladores del receptor de la serotonina 5-ht2c.
DE60307286T DE60307286T2 (de) 2002-06-19 2003-06-18 Verfahren zur Herstellung von 2-Methyl Piperazin Derivaten.
BR0311970-0A BR0311970A (pt) 2002-06-19 2003-06-18 Novos compostos, seu uso e preparação
MXPA04012711A MXPA04012711A (es) 2002-06-19 2003-06-18 Nuevos compuestos, su uso y preparacion.
EA200500045A EA008148B1 (ru) 2002-06-19 2003-06-18 Новые соединения, их применение и получение
EP03760997A EP1513831B1 (en) 2002-06-19 2003-06-18 Novel compounds, their use and preparation
SI200330493T SI1529043T1 (sl) 2002-06-19 2003-06-18 Postopek za pripravo 2-metil piperazinskih derivatov
CNB038141310A CN100484933C (zh) 2002-06-19 2003-06-18 新的吡嗪化合物及其在制备用于治疗与5-羟色胺相关的疾病的药物中的用途
NO20050270A NO20050270L (no) 2002-06-19 2005-01-17 Nye forbindelser, deres anvendelse og fremstilling
NO20050279A NO20050279D0 (no) 2002-06-19 2005-01-18 Ny fremgangsmate
HK05111675.4A HK1079526A1 (en) 2002-06-19 2005-12-19 A novel pyrazine compound and its use in the manufacture of a medicament for treating diseases related to serotonin
HK06100135.0A HK1080079B (zh) 2002-06-19 2006-01-04 製備2-甲基哌嗪衍生物的方法
US11/359,152 US7820677B2 (en) 2002-06-19 2006-02-22 Phosphoric acid addition salt of (2R)-1-[3-(2-{[2-(2-dimethylaminoethoxy)-3-pyridinyl]oxy}-ethoxy)-2-pyrazinyl]-2-methylpiperazine
CY20061101556T CY1106225T1 (el) 2002-06-19 2006-10-30 Διαδικασια για την παρασκευη της 2-μεθυλ πιπepαζινης
JP2010002229A JP5378241B2 (ja) 2002-06-19 2010-01-07 治療化合物
US12/817,833 US8030316B2 (en) 2002-06-19 2010-06-17 Malate salt of (2R)-methyl-1-{3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinyl}piperazine
US13/234,510 US20120004241A1 (en) 2002-06-19 2011-09-16 Succinate salt of (2r)-methyl-1-piperazine
US13/234,555 US8410113B2 (en) 2002-06-19 2011-09-16 (2R)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine and salts thereof
JP2013019444A JP2013116906A (ja) 2002-06-19 2013-02-04 新規方法
US13/768,641 US8835439B2 (en) 2002-06-19 2013-02-15 Pharmaceutical composition containing (2R)-methyl-1-3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinylpiperazine L-malate for treatment of serotonin-related diseases
JP2013142942A JP2013227336A (ja) 2002-06-19 2013-07-08 新規方法
US14/274,131 US20140329826A1 (en) 2002-06-19 2014-05-09 (2r)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine and salts thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202516A SE0202516D0 (sv) 2002-08-26 2002-08-26 Novel compounds, their use, and preparation

Publications (1)

Publication Number Publication Date
SE0202516D0 true SE0202516D0 (sv) 2002-08-26

Family

ID=20288798

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202516A SE0202516D0 (sv) 2002-06-19 2002-08-26 Novel compounds, their use, and preparation

Country Status (1)

Country Link
SE (1) SE0202516D0 (sv)

Similar Documents

Publication Publication Date Title
NL1025404A1 (nl) Pyrazolo-triazine verbindingen en gebruik daarvan.
CY2014041I1 (el) 2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
DK1423376T3 (da) Bicyklisk forbindelse, fremstilling og anvendelse deraf
DE60330207D1 (de) le
DE602004006169D1 (de) Substituierte 8'-pyri(mi)dinyl-dihydrospiro-äcycloalkylaminü-pyrimidoä1,2aüpyrimidin-6-onderivate
DE10393374D2 (de) Zusammensetzung
SE0500163L (sv) Sammansättning
DE60326590D1 (de) Tend lamotrigin
DE60305332D1 (de) IMIDAZOi1,2-AöPYRIDINE
DK1492934T3 (da) Dørenhed
DE50203644D1 (de) Abseilvorrichtung
NO20044140D0 (no) New Composition
ITMI20021327A1 (it) Nuove ossialchilpiperazine
SE0202516D0 (sv) Novel compounds, their use, and preparation
SE0202239D0 (sv) Novel use
SE0200393D0 (sv) Novel use
SE0200410D0 (sv) Novel use
SE0201152D0 (sv) New use
SE0202963D0 (sv) New use
SE0202837D0 (sv) New use
SE0201942D0 (sv) New use
SE0201941D0 (sv) New use
SE0101122D0 (sv) Novel use
SE0101037D0 (sv) Novel use
SE0103291D0 (sv) New use